Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Functional network segregation moderates the association between amyloid burden and cognitive decline
Lizhi Guo; Yajing Zhou; Hanna Lu; Helene H. Fung; Dag AarslandShow moreShow less
1. Department of Psychology, The Chinese University of Hong Kong, Shatin, Hong Kong; 2. Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology, & Neuroscience, King’s College London, London, UK; 3. Department of Forensic & Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK; 4. Department of Psychiatry, The Chinese University of Hong Kong, Shatin, Hong Kong; 5. The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China; 6. Centre of Age-Related Medicine, Stavanger University Hospital, Stavanger, NorwayShow moreShow less
Higher baseline dietary fat intake was associated with accelerated neurodegeneration among older adults at increased risk for Alzheimer’s disease: a longitudinal cohort study
Lei Fan; Yunyi Sun; Dandan Liu; Kimberly R. Pechman; Yukti Vyas; Timothy J. Hohman; Kaj Blennow; Henrik Zetterberg; Angela L. JeffersonShow moreShow less
1. Vanderbilt Memory and Alzheimer’s Center, Vanderbilt University School of Medicine, Nashville, USA; 2. Department of Neurology, Vanderbilt University Medical Center, Nashville, USA; 3. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, USA; 4. Vanderbilt Alzheimer’s Disease Research Center, Nashville, USA; 5. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; 6. Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; 7. Pitié-Salpêtrière Hospital, Paris Brain Institute, ICM, Sorbonne University, Paris, France; 8. Department of Neurology, Institute on Aging and Brain Disorders, Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, China; 9. Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom; 10. UK Dementia Research Institute at UCL, London, United Kingdom; 11. Hong Kong Center for Neurodegenerative Diseases, InnoHK, Hong Kong, China; 12. Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA; 13. Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, USA; 14. Centre for Brain Research, Indian Institute of Science Campus, Bangalore, India; 15. Department of Medicine, Vanderbilt University Medical Center, Nashville, USAShow moreShow less
Dynamic prediction of bidirectional CDR-stage transitions: locked external validation and calibration in ADNI and OASIS-3
Faizaan Fazal Khan; Vyshnavi Ramineni; Seong Won Jeong; Goo-Rak KwonShow moreShow less
1. Department of Information and Communication Engineering, Chosun University, Gwangju, Republic of Korea; 2. Institute of Well-Aging Medicare & Chosun University G-LAMP Project group, Chosun University, Gwangju, Republic of KoreaShow moreShow less
A pain in the Aß: a typographical plea to the amyloid community
Michael SchöllShow moreShow less
1. Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden; 2. Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden; 3. Department of Neuropsychiatry, Sahlgrenska University Hospital, Mölndal, SwedenShow moreShow less
Computerised cognitive training combined with nutritional counseling in mild cognitive impairment - results of a 2 × 2 factorial randomized controlled trial (BrainFit-nutrition study)
Julia-Sophia Scheuermann; Elmar Graessel; Etienne Hanslian; Julia Schiele; Melanie Dell’oro; Martin Schmitt; Michael Jeitler; Christian S. KesslerShow moreShow less
1. Section of Medical Psychology and Medical Sociology, Department of Psychiatry and Psychotherapy, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; 2. Center for Health Services Research in Medicine, Department of Psychiatry and Psychotherapy, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; 3. Department for Dementia Research and Nursing Science, University for Continuing Education Krems, Krems, Austria; 4. Department of Internal Medicine and Nature-Based Therapies, Immanuel Hospital Berlin, Berlin, Germany; 5. Institute of Social Medicine, Epidemiology and Health Economics, Charité – University Medical Center Berlin, Corporate Member of Freie Universitat Berlin, and Humboldt-Universitat Zu Berlin, Berlin, Germany; 6. Charité Competence Center for Traditional and Integrative Medicine (CCCTIM), Charité - University Medical Center Berlin, Corporate Member of Freie Universität, Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; 7. Department of Integrative Health Care and Prevention, University of Augsburg & University Hospital Augsburg, Augsburg, Germany; 8. Institute for General Practice and Interprofessional Care, University Hospital Tuebingen, Tuebingen, Germany; 9. Robert Bosch Center for Integrative Medicine and Health, Bosch Health Campus, Stuttgart, GermanyShow moreShow less
Plasma p-tau217 in real-world clinical practice: distribution across clinical diagnostic categories, clinician confidence, and impact on care pathways
Jean-Louis Bayart; Lise Colmant; Emilien Boyer; Flo Blondiaux Pirson; Gaëtane Picard; Francoise Pieret; Eric Mormont; Kurt Segers; Dragos Barglazan; Adrian Ivanoiu; Jonathan Douxfils; Bernard J. HanseeuwShow moreShow less
1. Department of Laboratory Medicine, Clinique St-Pierre, Ottignies, Belgium; 2. Department of Laboratory Medicine, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium; 3. Institute of NeuroScience (IoNS), Université Catholique de Louvain, Bruxelles, Belgium; 4. Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences, Faculty of Medicine, University of Namur, Namur, Belgium; 5. Department of Neurology, Saint-Luc University Hospital, Brussels, Belgium; 6. Department of Neurology, Clinique Saint-Pierre, Ottignies, Belgium; 7. Department of Neurology, Bruxelles, Belgium; 8. Department of Neurology, CHU UCL Namur, Yvoir, Belgium; 9. Department of Neurology, Brugmann University Hospital, Bruxelles, Belgium; 10. Department of Laboratory Medicine, Brugmann University Hospital, Bruxelles, Belgium; 11. WEL Research Institute, Wavre, Belgium; 12. Department of Radiology, Massachusetts General Hospital, the Gordon Center for Medical Imaging, Boston, USAShow moreShow less
FAQ
How long does Alzheimers Research & Therapy take to review a manuscript?
As of 2026-11-18, CrushSCI has 20 complete review records for Alzheimers Research & Therapy. The fastest paper went from submission to acceptance in 4 days (A pain in the Aß: a typographical plea to the amyloid community, received 2026-10-22, accepted 2026-10-26); the slowest took 335 days. The average is 146.4 days and the median is 117 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
